CervoMed Inc (CRVO)
23.67
-0.42
(-1.74%)
USD |
NASDAQ |
May 20, 10:18
CervoMed Shareholders Equity (Quarterly): 5.336M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 5.336M |
December 31, 2023 | 7.377M |
September 30, 2023 | 9.574M |
June 30, 2023 | 14.23M |
March 31, 2023 | 16.28M |
December 31, 2022 | -33.29M |
September 30, 2022 | 24.05M |
June 30, 2022 | 26.67M |
March 31, 2022 | 30.62M |
December 31, 2021 | 34.91M |
September 30, 2021 | 38.13M |
June 30, 2021 | 50.17M |
March 31, 2021 | 53.65M |
December 31, 2020 | 24.81M |
September 30, 2020 | 28.72M |
June 30, 2020 | 32.88M |
March 31, 2020 | 17.90M |
December 31, 2019 | 20.13M |
September 30, 2019 | 13.52M |
June 30, 2019 | 16.18M |
March 31, 2019 | 12.96M |
December 31, 2018 | 15.61M |
September 30, 2018 | 20.91M |
June 30, 2018 | 27.30M |
March 31, 2018 | 29.72M |
Date | Value |
---|---|
December 31, 2017 | 21.23M |
September 30, 2017 | 6.357M |
June 30, 2017 | 1.168M |
March 31, 2017 | -19.12M |
December 31, 2016 | 9.185M |
September 30, 2016 | 11.49M |
June 30, 2016 | 14.03M |
March 31, 2016 | 16.58M |
December 31, 2015 | -0.0416M |
September 30, 2015 | 19.07M |
June 30, 2015 | 31.81M |
March 31, 2015 | 35.25M |
December 31, 2014 | 38.17M |
September 30, 2014 | 42.80M |
June 30, 2014 | 45.30M |
March 31, 2014 | 12.21M |
December 31, 2013 | 6.459M |
September 30, 2013 | -6.289M |
June 30, 2013 | -8.543M |
March 31, 2013 | -19.71M |
December 31, 2012 | -18.39M |
September 30, 2012 | -6.031M |
June 30, 2012 | -5.074M |
March 31, 2012 | -2.137M |
December 31, 2011 | -16.03M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-33.29M
Minimum
Dec 2022
53.65M
Maximum
Mar 2021
21.59M
Average
22.09M
Median
Shareholders Equity (Quarterly) Benchmarks
GlucoTrack Inc | 3.197M |
AIM ImmunoTech Inc | 10.23M |
Perspective Therapeutics Inc | 229.89M |
Protalix BioTherapeutics Inc | 29.79M |
Armata Pharmaceuticals Inc | -56.51M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 7.997M |
Total Liabilities (Quarterly) | 2.661M |